Level B· Emerging clinical evidence with positive signalsRandomized Controlled TrialPubMed

The effect of combined low-level nd: YAG laser with mesenchymal stem cells in the healing of diabetic wounds: an experimental study.

TizMaghz A., Shojaei S., Tehrani P.

Randomized Controlled Trial on Type 2 Diabetes, Diabetic Foot, Chronic Wound, published in Arch Dermatol Res (2025) — summary generated from the PubMed abstract.

Open my reading list
Level B· Emerging clinical evidence with positive signalsEvidence level of this study

Several human studies show positive signals, while research methods and sample sizes continue to develop.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Randomized Controlled Trial
Journal
Arch Dermatol Res (2025)
Country
Germany
Reported sample size
—
Source database
PubMed
PMID
39873794
DOI
10.1007/s00403-024-03714-6
Citations
1

Abstract (original English)

Although the role of low-level laser therapy (LLLT) and human adipose-derived stem cells (hADSC) in accelerating diabetic wound healing has been proven, their synergistic effect is still debated. This study aimed to evaluate the individual and combined effects of LLLT and hADSC on wound healing and on biomechanical parameters in type 2 diabetic rabbits. In this experimental study, 40 rabbits with type 2 diabetes (induced by streptozotocin (STZ)) were included. Rabbits were randomly assigned with equal ratios to 4 groups, including the control group (group A), hADSCs alone (group B), the laser alone (group C), and the combined group of hADSCs cells with laser (group D). 30 days after diabetes, two wounds were created on the back of each rabbit. Immediately after creating a wound, hADSC was injected into two parts of the wound. In the laser groups, the wound site was treated with a low-power 660 nm laser for 4 weeks daily for 20-30 s. The number of closed wounds in the treatment group was evaluated 7, 15 and 30 days after the treatment. On the 15th and 30th days, a standard sample of each healing wound was sent for biomechanical evaluation. Thirty days after treatment, the combined effect of LLLT + hADSCs was superior to their individual effects on wound healing and biomechanical parameters (mean bending stiffness, maximum force, high-stress load, and energy absorption), while th

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Several human studies show positive signals, while research methods and sample sizes continue to develop.

How we grade evidence
AnimalsRabbitsWound HealingLow-Level Light TherapyDiabetes Mellitus, ExperimentalMesenchymal Stem Cell TransplantationHumansLasers, Solid-StateDiabetes Mellitus, Type 2Male

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research